Results
1 -
10 of
75Development of novel antibacterial drugs to combat multiple resistant organisms, Langenbeck's Archives of Surgery In vitro activity of ??-lactams and quinolones against AmpC ??-lactamase-producing Escherichia coli, Journal of Infection and Chemotherapy Monte Carlo simulation for evaluation of the efficacy of carbapenems and new quinolones against ESBL-producing Escherichia coli, Journal of Infection and Chemotherapy Monobactams and carbapenems for treatment of intraabdominal infections, Infection Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolated from Blood Samples and Antibiotic Utilization in a University Hospital in Japan, Infectious Diseases and Therapy Antimicrobial susceptibility of Enterococcus strains used in clinical practice as probiotics, Journal of Infection and Chemotherapy The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy, Journal of Infection and Chemotherapy In vitro activity of ??-lactams, macrolides, telithromycin, and fluoroquinolones against clinical isolates of Streptococcus pneumoniae: correlation between drug resistance and genetic characteristics, Journal of Infection and Chemotherapy In Vitro Activity and the Efficacy of Arbekacin, Cefminox, Fosfomycin, Biapenem Against Gram-Negative Organisms: New Treatment Options?, Proceedings of the National Academy of Sciences, India Section B: Biological Sciences New promising ??-lactamase inhibitors for clinical use, European Journal of Clinical Microbiology & Infectious Diseases